Loading ......
Usutu virus (USUV) is a mosquito-borne flavivirus belonging to the Japanese encephalitis virus (JEV) serocomplex, first identified in South Africa in 1959. Historically known as an avian pathogen, it gained prominence in Europe after causing significant mass mortality events in blackbirds (Turdus merula) starting in the early 2000s. USUV has since established endemic transmission cycles across much of Europe, with growing evidence of spillover infections in humans. While often asymptomatic, human infection can lead to severe neurological complications such as meningoencephalitis, paralleling its close relative West Nile virus (WNV). Its rapid geographic expansion, driven by climate change, globalization, and compatible bird and mosquito populations, exemplifies the dynamics of viral emergence.
Figure 1.Structure of usutu virus. (Cadar D,2022)
For decades after its discovery, USUV was considered a low-pathogenicity virus of limited geographic range in Africa. This perception changed dramatically in 2001 when it was linked to widespread die-offs of blackbirds and other songbirds in Austria. This event marked its successful introduction and establishment in Europe. Subsequent surveillance revealed its silent spread across the continent, facilitated by resident Culex mosquito vectors and migratory bird reservoirs. Concurrently, increased testing identified a growing number of human cases, ranging from febrile illness to severe neuroinvasive disease. USUV now serves as a prime model for studying flavivirus ecology, cross-species transmission, and the potential for "pathogen pollution" – the human-mediated spread of exotic viruses into new ecosystems.
| Clinical Presentation | Details |
| In Birds | USUV infection in its natural avian hosts, particularly blackbirds, often causes severe and fatal disease characterized by neurological signs (ataxia, tremors), lethargy, and multi-organ necrosis, leading to the characteristic "bird die-offs." |
| In Humans | The majority (~99%) of human infections are asymptomatic. Symptomatic disease typically manifests after a 3-14 day incubation period. Febrile Illness: The most common presentation includes fever, headache, malaise, myalgia, and often a maculopapular rash. This is usually self-limiting. Neuroinvasive Disease (Meningoencephalitis): In a small fraction of cases (<1%), the virus invades the central nervous system, causing acute flaccid paralysis, meningitis, encephalitis, or meningoencephalitis. Outcomes can include long-term neurological sequelae or death, particularly in immunocompromised patients. USUV neurotropism is a major public health concern. |
Most human USUV infections are asymptomatic, with only a small proportion of infected individuals developing clinical disease. Symptomatic cases typically present with a mild, self-limiting febrile illness characterized by fever, headache, myalgia, arthralgia, rash, and occasionally hepatitis or jaundice. Severe neuroinvasive disease occurs in a minority of cases, presenting with meningitis, encephalitis, or cranial nerve dysfunction, which may lead to long-term neurological sequelae or death.
Diagnosis of USUV infection is primarily based on laboratory testing, as clinical manifestations are nonspecific and can be confused with other flavivirus infections. Available diagnostic methods include: (1) serological testing to detect USUV-specific IgM and IgG antibodies (enzyme-linked immunosorbent assay, ELISA), (2) molecular testing (reverse transcription-polymerase chain reaction, RT-PCR) to detect viral RNA in blood, cerebrospinal fluid (CSF), or tissue samples, and (3) virus isolation from clinical samples (gold standard, but time-consuming and labor-intensive). Currently, there are no commercially available diagnostic tests for USUV in the United States, with testing limited to specialized laboratories such as the CDC Arbovirus Diagnostic Laboratory.
Usutu virus has rapidly evolved from an obscure avian pathogen to a public health issue of European relevance. Its ecological success story highlights the vulnerability of new regions to introduced arboviruses. The clinical overlap with WNV necessitates heightened diagnostic awareness. While the risk of severe neuroinvasive disease in humans is currently low, the virus's trajectory underscores the need for robust surveillance systems that integrate animal, human, and environmental health monitoring. Investing in the understanding of its molecular pathogenesis is critical for developing the diagnostic tools, vaccines, and therapeutics needed to mitigate its impact as its range continues to expand.
Reference
| Target | Cat. No. | Product Name | Host | Isotype | Application | |
| USUV NS1 | CABT-RM264 | Magic™ Mouse Anti-USUV NS1 Monoclonal antibody, clone 736H06 | Mouse | IgG2b | ELISA (cap), LFIA | Inquiry |
| CABT-RM265 | Magic™ Mouse Anti-USUV NS1 Monoclonal antibody, clone 736H07 | Mouse | IgG1 | ELISA (det), LFIA | Inquiry |
| Target | Cat. No. | Product Name | Host | |
| USUV | DAG-SY1 | Usutu virus NS1 protein (Vienna 2001) [His] | HEK293 | Inquiry |
Loading ......